All-at-Once Spatial Proteome Profiling: The PSPro Breakthrough

Study Background and Research Question

In multicellular organisms, tissues are composed of diverse cell types that interact within a spatially organized microenvironment. Deciphering the protein composition of distinct cell populations within intact tissues is critical to understanding physiological and pathological processes, including cancer progression and immune regulation. Traditional spatial proteomics platforms—such as laser microdissection-mass spectrometry (LMD-MS) and antibody-based imaging—have advanced our ability to map protein distributions, but face inherent trade-offs: high spatial resolution often comes at the expense of throughput or proteome depth, and vice versa. Mao et al. sought to overcome these barriers with a new strategy capable of profiling multiple cell types simultaneously from a single tissue section, while preserving spatial context and maximizing protein coverage (Mao et al., 2025).

Key Innovation from the Reference Study

The central innovation of Mao et al.'s study is the development of PSPro (Proximity labeling for Spatial Proteomics), a workflow that combines precise antibody-targeted proximity biotinylation with efficient affinity purification. Unlike traditional methods that require serial or sequential isolation of cell populations, PSPro enables the "all-at-once" capture and quantification of proteomes from multiple, spatially defined cell types within a single tissue slice. This approach leverages the specificity of antibody labeling and the spatial restriction of proximity-based biotinylation to achieve cell-type-resolved proteome mapping with sub-micrometer precision.

Methods and Experimental Design Insights

PSPro's methodology incorporates several critical steps:

• Antibody-Targeted Proximity Biotinylation: Antibodies directed against cell-type-specific surface markers are conjugated to peroxidase enzymes. In the presence of biotin-phenol and hydrogen peroxide, these complexes catalyze the deposition of biotin onto proteins in close proximity to the antibody target, enabling high spatial selectivity.
• Optimized Labeling Parameters: The authors fine-tuned labeling conditions—including antibody concentration, incubation time, and biotin-phenol exposure—to maximize selectivity and proteome coverage. This careful optimization was benchmarked against established proteomics workflows, such as flow cytometry and LMD-MS.
• Affinity Purification and Mass Spectrometry: Biotinylated proteins are isolated using streptavidin beads, then digested and analyzed by mass spectrometry to generate comprehensive, cell-type-specific proteomic profiles.
• Incorporation of Laser Microdissection: For enhanced spatial resolution, PSPro can be coupled with LMD to isolate specific tissue regions before proximity labeling, allowing comparative analysis of subpopulations within the same tissue context.

This workflow allows researchers to circumvent the throughput limitations of serial microdissection, while maintaining the spatial and cell-type resolution required for modern tissue biology studies.

Protocol Parameters

• Antibody conjugation: Use peroxidase-conjugated antibodies specific to cell surface markers; optimize antibody concentration for each target cell type.
• Biotin-phenol incubation: 5–10 minutes at room temperature, with concentrations adjusted (e.g., 500 μM) based on tissue thickness and labeling efficiency.
• Hydrogen peroxide exposure: Short-term exposure (1–2 minutes at 1 mM) to initiate biotinylation while minimizing off-target labeling.
• Affinity purification: Capture biotinylated proteins with streptavidin beads; wash thoroughly to reduce background.
• Optional LMD integration: For subregions, perform laser microdissection prior to labeling to isolate specific anatomical areas.

Researchers should adjust these parameters based on tissue type, antibody specificity, and desired spatial resolution, as detailed in the reference study.

Core Findings and Why They Matter

Applying PSPro to pancreatic tumor and spleen slices, Mao et al. demonstrated the ability to profile proteomes of ten distinct cell types simultaneously, enriching thousands of proteins—including cell-type-defining markers—from single tissue sections. Importantly, the method revealed spatial heterogeneity among cancer and immune cell subpopulations within individual tumor slices, providing new insights into microenvironmental organization and cell-cell interactions in situ.

The benchmarking experiments confirmed that PSPro delivers comparable or superior selectivity and proteome depth relative to established flow cytometry and LMD-MS workflows, but with enhanced throughput and spatial resolution. This positions PSPro as a versatile and scalable platform for spatial proteomics, particularly in the context of complex tissues where rare or intermingled cell types must be resolved efficiently.

These findings have significant implications for cancer biology, immunology, and tissue pathology, where unraveling the spatial and molecular heterogeneity of cellular niches is critical for understanding disease mechanisms and identifying therapeutic targets.

Comparison with Existing Internal Articles

Several internal resources discuss the challenges and solutions in detecting low-abundance proteins and nucleic acids within fixed tissues—a key requirement for successful spatial proteomics. For instance, one article highlights how tyramide signal amplification (TSA) enables robust detection of scarce biomolecules in immunohistochemistry (IHC), facilitating studies where conventional immunofluorescence lacks sensitivity. Another resource, focused on workflow optimization, emphasizes the importance of HRP-catalyzed tyramide deposition and bright fluorophores (e.g., Cy3) for streamlining fluorescence microscopy detection in molecular pathology and translational research.

While these articles primarily address imaging-based detection, Mao et al.'s PSPro extends spatial biomolecule profiling into the deep proteomics domain by enabling the enrichment and identification of thousands of low-abundance proteins in a spatially resolved, cell-type-specific manner. Both approaches underscore the value of maximizing signal amplification and tissue compatibility, whether for imaging or mass spectrometry-based applications. The integration of advanced amplification chemistries and affinity-based purification—central to both TSA workflows and PSPro—represents a convergence of strategies for overcoming sensitivity barriers in tissue analysis.

Limitations and Transferability

Despite its advantages, PSPro is not without limitations. The method relies on the availability of high-quality, cell-type-specific antibodies, and its effectiveness depends on careful optimization of labeling parameters to balance selectivity and coverage. While PSPro can be adapted to various tissue types and cell populations, its performance in highly autofluorescent tissues or those with limited antibody accessibility may require further validation.

Additionally, while the integration of LMD enhances spatial resolution, it introduces extra procedural complexity and may constrain throughput for large-scale studies. The requirement for mass spectrometric infrastructure and expertise also poses practical considerations for widespread adoption. Nonetheless, the modular nature of PSPro permits adaptation to emerging tissue imaging and proteomics platforms, making it a valuable addition to the spatial biology toolkit.

Research Support Resources

To facilitate high-sensitivity detection and signal amplification in spatial proteomics and related workflows, researchers can leverage advanced reagents such as the Cy3 TSA Fluorescence System Kit (SKU K1051). This kit, available from APExBIO, employs HRP-catalyzed tyramide deposition to boost fluorescence microscopy detection of low-abundance biomolecules in IHC, ICC, and in situ hybridization. Its compatibility with standard fluorescence microscopy (Cy3 excitation at 550 nm, emission at 570 nm) and robust signal amplification make it suitable for validating target protein localization or optimizing antibody labeling steps in workflows analogous to PSPro. For detailed best practices and scenario-driven guidance, see internal articles such as high-sensitivity detection scenarios and workflow optimization strategies.

By integrating optimized amplification tools and proximity-based proteomics, researchers are now equipped to interrogate tissue proteomes with unprecedented spatial and molecular resolution, as demonstrated by the PSPro approach (Mao et al., 2025).